6/25/2013 8:16:55 AM
Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!
Johnson & Johnson's DePuy Orthopaedics subsidiary lands a supplemental pre-market approval from the FDA for use of its Trumatch Personalized Solutions system with its already-approved Sigma RP knee implant. DePuy Orthopaedics said the FDA granted a supplemental pre-market approval to use special software to customize its Sigma RP knee implant for individual patients physiologies. The Johnson & Johnson (NYSE:JNJ) subsidiary said the federal watchdog agency approved the use of its Trumatch Personalized Solutions system with its Sigma RP knee implant.
Help employers find you! Check out all the jobs and post your resume.
comments powered by